Literature DB >> 30123923

The anti-angiogenic potential of (±) gossypol in comparison to suramin.

Gönül Ulus1, A Tansu Koparal2, Kemal Baysal3, Günay Yetik Anacak4, N Ülkü Karabay Yavaşoğlu5.   

Abstract

Cotton, a staple fiber that grows around the seeds of the cotton plants (Gossypium), is produced throughout the world, and its by products, such as cotton fibers, cotton-seed oil, and cottonseed proteins, have a variety of applications. Cotton-seed contains gossypol, a natural phenol compound. (±)-Gossypol is a yellowish polyphenol that is derived from different parts of the cotton plant and contains potent anticancer properties. Tumor growth and metastasis are mainly related to angiogenesis; therefore, anti-angiogenic therapy targets the new blood vessels that provide oxygen and nutrients to actively proliferating tumor cells. The aim of the present study was to evaluate the anti-angiogenic potential of (±)-gossypol in vitro. (±)-Gossypol has anti-proliferative effects on cancer cell lines; however, its anti-angiogenic effects on normal cells have not been studied. Anti-proliferative activities of gossypol assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, anti-angiogenic activities using tube formation assay, and cell migration inhibition capability using a wound-healing assay on human umbilical vein endothelial cells (HUVECs) were revealed. (±)-Gossypol displayed the following potent anti-angiogenic activities in vitro: it inhibited the cell viability of HUVECs, it inhibited the migration of HUVECs, and disrupted endothelial tube formation in a dose-dependent manner. In addition, the anti-angiogenic effects of (±)-gossypol were investigated in ovo in a model using a chick chorioallantoic membrane (CAM). Decreases in capillary density were assessed and scored. (±)-Gossypol showed dose-dependent anti-angiogenic effects on CAM. These findings suggest that (±)-gossypol can be used as a new anti-angiogenic agent.

Entities:  

Keywords:  (±)-Gossypol; Anti-angiogenesis; Human umbilical vein endothelial cell (HUVEC); Suramin

Year:  2018        PMID: 30123923      PMCID: PMC6269362          DOI: 10.1007/s10616-018-0247-z

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  35 in total

1.  The effects of gossypol on the invasiveness of MAT-LyLu cells and MAT-LyLu cells from the metastasized lungs of MAT-LyLu-bearing Copenhagen rats.

Authors:  J Jiang; S K Kulp; Y Sugimoto; S Liu; Y C Lin
Journal:  Anticancer Res       Date:  2000 Nov-Dec       Impact factor: 2.480

2.  Amphiphilic suramin dissolves Matrigel, causing an 'inhibition' artefact within in vitro angiogenesis assays.

Authors:  Natalie L Prigozhina; Andrew J Heisel; Jordan R Seldeen; Nicholas D P Cosford; Jeffrey H Price
Journal:  Int J Exp Pathol       Date:  2013-09-02       Impact factor: 1.925

3.  Versatile hyaluronic acid modified AQ4N-Cu(II)-gossypol infinite coordination polymer nanoparticles: Multiple tumor targeting, highly efficient synergistic chemotherapy, and real-time self-monitoring.

Authors:  Shihong Shen; Youshen Wu; Ke Li; Ya Wang; Jimin Wu; Yun Zeng; Daocheng Wu
Journal:  Biomaterials       Date:  2017-11-03       Impact factor: 12.479

4.  Gossypol treatment of recurrent adult malignant gliomas.

Authors:  P Bushunow; M M Reidenberg; J Wasenko; J Winfield; B Lorenzo; S Lemke; B Himpler; R Corona; T Coyle
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

5.  Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial.

Authors:  C Van Poznak; A D Seidman; M M Reidenberg; M M Moasser; N Sklarin; K Van Zee; P Borgen; M Gollub; D Bacotti; T J Yao; R Bloch; M Ligueros; M Sonenberg; L Norton; C Hudis
Journal:  Breast Cancer Res Treat       Date:  2001-04       Impact factor: 4.872

6.  The (-)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer.

Authors:  Suling Liu; Samuel K Kulp; Yasuro Sugimoto; Jiahua Jiang; Hsiang-Lin Chang; Michael K Dowd; Peter Wan; Young C Lin
Journal:  Anticancer Res       Date:  2002 Jan-Feb       Impact factor: 2.480

7.  Differential cytotoxic effect of gossypol on human melanoma, colon carcinoma, and other tissue culture cell lines.

Authors:  G P Tuszynski; G Cossu
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

8.  The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway.

Authors:  Jiahua Jiang; Yasuro Sugimoto; Suling Liu; Hsiang-Lin Chang; Kah-Young Park; Samuel K Kulp; Young C Lin
Journal:  Anticancer Res       Date:  2004 Jan-Feb       Impact factor: 2.480

9.  The in vitro effect of gossypol and its interaction with salts on conidial germination and viability of Fusarium oxysporum sp. vasinfectum isolates.

Authors:  E Turco; C Vizzuso; S Franceschini; A Ragazzi; F M Stefanini
Journal:  J Appl Microbiol       Date:  2007-12       Impact factor: 3.772

10.  Influence of levamisole and other angiogenesis inhibitors on angiogenesis and endothelial cell morphology in vitro.

Authors:  Tina Friis; Anne-Marie Engel; Christine D Bendiksen; Line S Larsen; Gunnar Houen
Journal:  Cancers (Basel)       Date:  2013-06-24       Impact factor: 6.639

View more
  2 in total

1.  Dihydroartemisinin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cell by Upregulating Tumor Necrosis Factor via JNK/NF-κB Pathways.

Authors:  Long Wu; Yanlei Cheng; Junjian Deng; Weiping Tao; Junjie Ye
Journal:  Evid Based Complement Alternat Med       Date:  2019-08-25       Impact factor: 2.629

Review 2.  Endothelial Cell Glucose Metabolism and Angiogenesis.

Authors:  Wa Du; Lu Ren; Milton H Hamblin; Yanbo Fan
Journal:  Biomedicines       Date:  2021-02-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.